IMV Inc News - IMV

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Horizon Technology Finance Announces First Quarter 2023 Financial Results

Horizon Technology Finance Announces First Quarter 2023 Financial Results PR Newswire FARMINGTON, Conn., May 2, 2023 - First Quarter 2023 Net...

Suspension de la négociation par l'OCRCVM - IMV

Suspension de la négociation par l'OCRCVM - IMV Canada NewsWire TORONTO, le 1er mai 2023 TORONTO, le 1er mai 2023 /CNW/ - L'OCRCVM a...

IIROC Trading Halt - IMV

IIROC Trading Halt - IMV Canada NewsWire TORONTO, May 1, 2023 TORONTO, May 1, 2023 /CNW/ - The following issues have been halted by...

TMX Group, IMV, C-Suite at The Open

TMX Group, IMV, C-Suite at The Open Canada NewsWire TORONTO, Dec. 9, 2020 TORONTO, Dec. 9, 2020 /CNW/ - Fred Ors, CEO, IMV Inc. (TSX: IMV...

IMV fournit une mise à jour sur son programme de vaccin COVID-19

Sélectionnée par le gouvernement canadien pour recevoir un financement supplémentaire, portant le soutien à un total de 10 millions de dollars à...

IMV to Participate at Four Upcoming Investor Conferences

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer...

IMV Inc. Announces Second Quarter 2020 Financial Results

Rapidly progressing DPX-COVID-19, including Health Canada agreement on Phase 1 clinical study design protocol, with preliminary results expected...

IMV reçoit des subventions de la part d’agences gouvernementales pour la phase 1 du développement clinique du vaccin cont...

Ces subventions d’un total de 4,75 millions soutiendront la fabrication du vaccin et l’étude clinique de phase 1 IMV Inc. (Nasdaq: IMV; TSX:...

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

Contribution totalling Cdn$4.75 Million will support Phase 1 clinical development and manufacturing of DPX-COVID-19 IMV Inc. (Nasdaq: IMV; TSX:...

IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer...

IMV to Present at BTIG’s Virtual Biotechnology Conference

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that...

IMV Announces Appointment of Michael P. Bailey to Board of Directors

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines...

IMV annonce une mise-à-jour des progrès rapides de son programme de développement de son vaccin candidat contre la COVID-19

Reçoit l’accord de Santé Canada à l’égard du design d’un essai clinique de phase 1, lequel comprendra aussi une cohorte d'adultes âgés de 56 ans...

IMV Updates Rapid Progress on COVID-19 Vaccine Program

Received agreement with Health Canada on Phase 1 clinical study design protocol which also includes older patients of 56 years and above...

IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus

IMV Inc. (“IMV” or the “Company”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company, today announced that in order to maintain...

Triple nickle 2 years ago

Ready to pop wide open

👍️0

Triple nickle 2 years ago

Loading this dip

IMV

👍️0

IOUBLOKE1 2 years ago

Laar minute of the day drops 30%

👍️0

IOUBLOKE1 2 years ago

No comments ihub on the offering.

👍️0

heyitsmeagain 3 years ago

HOT 1:5 PT

👍️0

heyitsmeagain 3 years ago

Up up

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

IMV Inc (IMV)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

IMV News

Horizon Technology Finance Announces First Quarter 2023 Financial Results

Suspension de la négociation par l'OCRCVM - IMV

IIROC Trading Halt - IMV

TMX Group, IMV, C-Suite at The Open

IMV fournit une mise à jour sur son programme de vaccin COVID-19

IMV to Participate at Four Upcoming Investor Conferences

IMV Inc. Announces Second Quarter 2020 Financial Results

IMV reçoit des subventions de la part d’agences gouvernementales pour la phase 1 du développement clinique du vaccin cont...

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020

IMV to Present at BTIG’s Virtual Biotechnology Conference

IMV Announces Appointment of Michael P. Bailey to Board of Directors

IMV annonce une mise-à-jour des progrès rapides de son programme de développement de son vaccin candidat contre la COVID-19

IMV Updates Rapid Progress on COVID-19 Vaccine Program

IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus

IMV Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

IMV Inc (IMV) News

IMV Inc (IMV)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

IMV News

Horizon Technology Finance Announces First Quarter 2023 Financial Results

Suspension de la négociation par l'OCRCVM - IMV

IIROC Trading Halt - IMV

TMX Group, IMV, C-Suite at The Open

IMV fournit une mise à jour sur son programme de vaccin COVID-19

IMV to Participate at Four Upcoming Investor Conferences

IMV Inc. Announces Second Quarter 2020 Financial Results

IMV reçoit des subventions de la part d’agences gouvernementales pour la phase 1 du développement clinique du vaccin cont...

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020

IMV to Present at BTIG’s Virtual Biotechnology Conference

IMV Announces Appointment of Michael P. Bailey to Board of Directors

IMV annonce une mise-à-jour des progrès rapides de son programme de développement de son vaccin candidat contre la COVID-19

IMV Updates Rapid Progress on COVID-19 Vaccine Program

IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus

IMV Discussion

Your Recent History

Go Ad-Free